SMW Free Realtime Trade Alerts -- Our Last 2 Trade Alerts were VII and NFEC, easy 40-75% wins in minutes, Join Today for FREE!!

Galectin Therapeutics Inc Unit Cons of 2 shs + 1 Wt
(NASDAQ : GALTU)

( )
GALTU PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
Loading GALTU News...
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc.
2.31%88.551.6%$823.72m
BIIBBiogen Inc.
-0.15%287.351.2%$582.20m
CELGCelgene Corporation
0.38%107.931.1%$475.08m
AMGNAmgen Inc.
0.54%166.561.2%$473.09m
REGNRegeneron Pharmaceuticals, Inc.
0.91%394.903.1%$311.76m
ALXNAlexion Pharmaceuticals, Inc.
1.32%127.462.6%$257.08m
TSROTESARO, Inc.
-1.05%91.0218.0%$220.16m
BMRNBioMarin Pharmaceutical Inc.
-0.84%92.793.9%$192.43m
ILMNIllumina, Inc.
-0.08%150.645.1%$157.78m
MDVNMedivation, Inc.
0.77%63.112.6%$134.52m
VRTXVertex Pharmaceuticals Incorporated
2.00%95.771.7%$133.83m
JUNOJuno Therapeutics, Inc.
0.65%29.327.9%$104.16m
AAgilent Technologies, Inc.
-0.92%46.151.9%$93.70m
INCYIncyte Corporation
0.02%86.432.2%$80.10m
ALNYAlnylam Pharmaceuticals, Inc
1.08%66.205.2%$63.94m

Company Profile

Galectin Therapeutics, Inc. operates as a biotechnology company, which engages in drug research and development to create new therapies for fibrotic disease and cancer. Its drug candidates are based on the method of targeting galectin proteins, which are key mediators of biologic and pathologic function and its focus is on diseases with serious, life-threatening consequences to patients and those where current treatment options are limited. The company was founded by James C. Czirr and Anatole A. Kltyosov on July 10, 2000 and is headquartered in Norcross, GA.